Catatan efek · kuartal yang diarsipkan
VRTX
Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
21Pemegang yang dilacak
+1Δ pemegang
60.08MSaham yang dipegang
$24.19BNilai yang dilaporkan
+1Posisi baru
−0Keluar
Input momentum (manajer yang sebanding):
keluasan pemegang +5.0% ·
aliran saham +3.2% ·
posisi baru bersih +4.8%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q4 2024
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | -1 | 212.02M | $105.17B | +5 | −5 |
| Q1 2026 | 178 | 0 | 208.95M | $93.29B | +5 | −6 |
| Q4 2025 | 177 | -1 | 219.78M | $99.62B | +2 | −2 |
| Q3 2025 | 26 | +1 | 120.93M | $47.35B | +1 | −1 |
| Q2 2025 | 23 | +1 | 112.15M | $49.92B | +3 | −2 |
| Q1 2025 | 19 | -2 | 60.41M | $29.28B | — | −2 |
| Q4 2024 | 21 | +1 | 60.08M | $24.19B | +1 | — |
| Q3 2024 | 19 | 0 | 46.24M | $21.49B | — | — |
| Q2 2024 | 19 | — | 46.47M | $21.77B | — | — |
Siapa yang memegangnya · Q4 2024
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 28.33M | +5.7% | $11.41B | 1.7% | ▲ Add | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasif) | 11.98M | — | $4.82B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 5.92M | +23.3% | $2.38B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 11 | Geode Capital Management ✦ (pasif) | 5.65M | -4.8% | $2.27B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasif) | 5.65M | -4.8% | $2.27B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 13 | Norges Bank ✦ (pasif) | 3.41M | +0.1% | $1.37B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 1.69M | -4.4% | $680.85M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 1.69M | -4.4% | $680.85M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 1.40M | -14.4% | $562.66M | 0.8% | ▼ Trim | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 310.64K | +95.0% | $125.10M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 265.68K | +92.0% | $106.99M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 265.68K | +92.0% | $106.99M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 245.78K | -48.9% | $98.98M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 245.78K | -48.9% | $98.98M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 245.78K | -48.9% | $98.98M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 245.78K | -48.9% | $98.98M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 245.78K | -48.9% | $98.98M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 209.24K | -39.6% | $84.26M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 26 | Marshall Wace ✦ | 194.00K | -20.5% | $78.12M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 27 | Marshall Wace ✦ | 194.00K | -20.5% | $78.12M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 162.18K | +222.9% | $65.31M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 162.18K | +222.9% | $65.31M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 30 | Baillie Gifford ✦ | 149.84K | +6.6% | $60.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 31 | Baillie Gifford ✦ | 149.84K | +6.6% | $60.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 32 | Baillie Gifford ✦ | 149.84K | +6.6% | $60.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 33 | Baillie Gifford ✦ | 149.84K | +6.6% | $60.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 34 | Tweedy, Browne ✦ | 40.63K | -24.2% | $16.36M | 1.1% | ▼ Trim | 3 | SEC ↗ |
| 35 | Two Sigma Investments ✦ | 33.16K | -79.3% | $13.35M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 36 | Gotham Asset Management ✦ | 30.11K | +11.0% | $12.13M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 37 | Fisher Asset Management ✦ | 29.91K | +10.7% | $12.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 38 | ARK Investment Management ✦ | 25.35K | -50.4% | $10.21M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 39 | Arrowstreet Capital ✦ | 9.27K | Baru | $3.73M | 0.0% | New | 1 | SEC ↗ |
| 40 | Bridgewater Associates ✦ | 710 | -79.4% | $285,917 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Arrowstreet Capital | $3.73M | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1,678 pemegang, 225.07M saham, $98.10B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q4 2024 ·
Metodologi ·
Dapatkan ini melalui API